Abstract:Zidovudine/lamivudine tablets are nucleoside reverse transcriptase inhibitors that are used to treat human immunodeficiency virus. The objective of this study was to investigate the bioequivalence and pharmacokinetics (PKs) of test and reference preparations of zidovudine/lamivudine tablets in healthy Chinese subjects. We designed a randomized, open, single-center, single-dose, 2-crossover experiment with a 7-day washout period involving 20 healthy subjects. The subjects were given a single dose of the test or reference preparation after fasting overnight for 10 hours. Blood samples were subsequently collected at scheduled time points from 0 hour (preadministration) up to 24 hours postadministration. The plasma concentrations of zidovudine and lamivudine were determined by a validated ultra-performance liquid chromatography-tandem mass spectrometry method. Analysis of variance (ANOVA) was used to compare differences in the mean values of key PK parameters between the 2 preparations. Bioequivalence was evaluated by 2 one-sided t-tests and 90% confidence intervals (CIs) of the geometric mean ratio (GMR). In total, 19 of the 20 subjects completed the trial. Based on the analysis of PK parameters, the relative bioavailability of zidovudine and lamivudine was 101.1% +/- 2.0% and 100.3% +/- 1.5%, respectively. ANOVA found no significant difference in primary PK parameters when compared between the 2 formulations, and the 90% CIs of the GMR of the 2 formulations were within the bioequivalence margins of 80%-125%. No serious adverse events occurred. Thus, we confirmed that the 2 preparations were bioequivalent in healthy Chinese volunteers. Our analysis demonstrated that both products showed good tolerance in all subjects.

Study of Relative Bioavailability of Aciclovir Tablet in Healthy Volunteers

Study on relative bioavailability of acyclovir tablets in healthy volunteers

Pharmacokinetics and Relative Bioavailability Study of Valaciclovir Hydrochloride Tablets in Chinese Healthy Volunteers

Bioequivalence of Valaciclovir Hydrochlordide Tablets in Healthy Volunteers

Study on bioequivalence of cilostazol table in healthy volunteers

Relative Bioavailability and Bioequivalence of Famciclovir Tablets in Healthy Volunteers

Pharmacokinetics and Safety of Pitavastatin Calcium Tablets in Chinese Healthy Volunteers after a Single Oral Dose Administration

Bioequivalence of Valaciclovir Capsules in Human

[Pharmacokinetics and Relative Bioavailability of Ziprasidone Tablets in Chinese Healthy Volunteers].

Bioequivalence of Clarithromycin Dispersed Tablet in Health Volunteers

Pharmacokinetics and relative bioavalability of clarithromycin tablets

Bioequivalence Study of Voriconazole Tablet in Healthy Chinese Male Volunteers

Pharmacokinetics and Relative Bioavailability of Azithromycin Tabletsin Healthy Volunteers

Relative Bioavailability of Clarithromycin in Healthy Volunteers

Relative bioavailability of domestic and imported clarithromycin granules for oral suspension in Chinese healthy volunteers

Study of the Bioequivalence of Gliclazide in Chinese Healthy Volunteers

Bioequivalence and Pharmacokinetics Study of Two Zidovudine/Lamivudine Tablets in Chinese Healthy Volunteers

Pharmacokinetics And Relative Bioavailability Of Two Allopurinol Tablets In Healthy Chinese Volunteers

Bioequivalence of Azithromycin Tablets in Healthy Volunteers

Pharmacokinetic and Bioequivalence Evaluation of Single-Tablet and Separate-Tablet Regimens for Ainuovirine, Lamivudine, and Tenofovir Disoproxil Fumarate in Chinese Healthy Subjects

Study On Bioequivalence Of Voriconazole Dispersible Tablets In Healthy Volunteers